Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 31, 2001

View Archived Issues

FDA approves insulin analogue for pump therapy

Positive phase I/II AlloMune results for end-stage lymphoma

Kyowa Hakko develops new antibody technology

GeneProt delivers potential protein candidates to Novartis

Preparation and use of new thienopyrimidinediones discovered at AstraZeneca

Uriach researchers identify selective COX-2 inhibitors with antiinflammatory activity

Schering discloses new series of antiangiogenic agents

Novel epothilone derivatives from Schering act as microtubule-stabilizing agents

Vancomycin analogues with activity against enterococci and staphylococci

Inhibitors of shikamate pathway enzyme under development at Arrow as novel antibiotics

Design and preclinical evaluation of a new class of bacterial peptide deformylase inhibitors

Oxapenem beta-lactamase inhibitors reported at ICAAC to extend spectrum of cephalosporins

MitoKor and Pfizer extend mitochondrial dysfunction collaboration

ISV-401 enters phase II trials for bacterial conjunctivitis

Schering and MorphoSys enter therapeutic and diagnostic R&D agreement

AHP and Elan form sleep disorder alliance

Preliminary preclinical data demonstrate tumor vascular targeting efficacy of OXI-4503

Celera and Syrrx enter structural proteomics collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...